We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
-6.57%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$992B
AUM Growth
-$120B
Cap. Flow
-$16.9B
Cap. Flow %
-1.7%
Top 10 Hldgs %
27.94%
Holding
3,085
New
108
Increased
1,637
Reduced
1,059
Closed
107

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$4.45B
2
JPM icon
JPMorgan Chase
JPM
+$2.22B
3
TEAM icon
Atlassian
TEAM
+$2.08B
4
NVDA icon
NVIDIA
NVDA
+$1.81B
5
AAPL icon
Apple
AAPL
+$1.67B

Sector Composition

Rank Sector Weight
1 Technology 26.79%
2 Healthcare 17.19%
3 Consumer Discretionary 15.16%
4 Financials 10.74%
5 Communication Services 10.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSGS icon
876
Madison Square Garden
MSGS
$9.94B
$65.1M 0.01%
363,146
+44,029
+14% +$7.5M
PRU icon
877
Prudential Financial
PRU
$43B
$65M 0.01%
550,441
-28,068
-5% -$3.19M
IVZ icon
878
Invesco
IVZ
$14.3B
$64.9M 0.01%
2,816,367
+315,393
+13% +$7M
HHH icon
879
Howard Hughes
HHH
$4.04B
$64.7M 0.01%
654,989
-40,870
-6% -$3.77M
CERT icon
880
Certara
CERT
$1.24B
$64.6M 0.01%
3,008,819
-205,403
-6% -$4.94M
CLW icon
881
Clearwater Paper
CLW
$354M
$64.5M 0.01%
2,301,320
+90,286
+4% +$2.83M
GBIO
882
DELISTED
Generation Bio
GBIO
$64.3M 0.01%
876,369
+11,657
+1% +$675K
PTCT icon
883
PTC Therapeutics
PTCT
$6.01B
$64.1M 0.01%
1,718,458
-388,103
-18% -$15M
CROX icon
884
Crocs
CROX
$6.36B
$64M 0.01%
837,076
+5,683
+0.7% +$538K
GMED icon
885
Globus Medical
GMED
$11.5B
$63.5M 0.01%
861,267
+4,029
+0.5% +$280K
BC icon
886
Brunswick
BC
$5.29B
$63.4M 0.01%
784,227
-57,006
-7% -$5.26M
PAYO icon
887
Payoneer
PAYO
$2.42B
$63.4M 0.01%
14,218,433
-5,509,227
-28% -$27.9M
CRL icon
888
Charles River Laboratories
CRL
$13.4B
$62.8M 0.01%
221,263
+1,892
+0.9% +$583K
GTLS
889
DELISTED
Chart Industries
GTLS
$62.4M 0.01%
363,418
+158,490
+77% +$22.3M
HALO icon
890
Halozyme
HALO
$11.4B
$62.4M 0.01%
1,565,247
+10,703
+0.7% +$381K
SQM icon
891
Sociedad Química y Minera de Chile
SQM
$20.6B
$62.4M 0.01%
+729,006
New +$46.7M
SNCY
892
DELISTED
Sun Country Airlines
SNCY
$62.4M 0.01%
2,383,452
+322,450
+16% +$8.4M
SEER icon
893
Seer Inc
SEER
$116M
$62M 0.01%
4,071,027
-441,834
-10% -$6.84M
VC icon
894
Visteon
VC
$2.86B
$62M 0.01%
567,839
+4,520
+0.8% +$492K
BCO icon
895
Brink's
BCO
$4.72B
$61.9M 0.01%
910,275
-113,569
-11% -$7.77M
DRE
896
DELISTED
Duke Realty Corp.
DRE
$61.7M 0.01%
1,062,610
-60,317
-5% -$3.42M
AFL icon
897
Aflac
AFL
$60.7B
$61.6M 0.01%
956,612
-63,067
-6% -$3.95M
BHVN
898
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$61.2M 0.01%
515,771
+49,794
+11% +$6.21M
EBC icon
899
Eastern Bankshares
EBC
$5.37B
$61M 0.01%
2,832,187
+30,751
+1% +$655K
CARR icon
900
Carrier Global
CARR
$52.2B
$61M 0.01%
1,329,810
-69,728
-5% -$3.28M

Similar funds

T. Rowe Price Associates's Q1 2022 Portfolio in Review

As of Q1 2022, T. Rowe Price Associates held 3,085 positions worth $992B, down 11% from $1.11T the previous quarter. Its ten largest holdings account for 28% of the portfolio.

T. Rowe Price Associates's Q1 2022 filing shows 108 new, 1,637 increased, 1,059 reduced and 107 closed positions. Its largest new stake was Nutrien: 6,143,560 shares worth $639M. The largest sale was Alphabet (Google) Class C, an estimated $3.24B.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • T. Rowe Price Associates's largest Q1 2022 buy was Nutrien: 6,143,560 shares worth $639M.
  • T. Rowe Price Associates added most to Tesla in Q1 2022, an estimated $4.45B increase.
  • T. Rowe Price Associates's biggest Q1 2022 reduction was Alphabet (Google) Class C, cutting an estimated $3.24B.
  • T. Rowe Price Associates fully exited Xilinx Inc in Q1 2022, selling an estimated $481M.
  • T. Rowe Price Associates's ten largest holdings make up 28% of its $992B portfolio in Q1 2022.
  • T. Rowe Price Associates opened 108 new positions and closed 107 in Q1 2022.
  • T. Rowe Price Associates's portfolio value fell 11% quarter-over-quarter to $992B.

Based on T. Rowe Price Associates's 13F filing for Q1 2022, filed 16 May 2022.